EMILY HENRY: Open Payments
NPI 1841823416 · LOUISVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$519 in 28 payments from 14 companies in 2025. Trend: 2023 $618 · 2024 $716 · 2025 $519
Food & beverage: $519
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 4 | $96 |
| ABBVIE INC. | 3 | $86 |
| MAYNE PHARMA COMMERCIAL LLC | 4 | $43 |
| Radius Health, Inc. | 2 | $41 |
| Organon LLC | 3 | $37 |
| Amgen Inc. | 2 | $37 |
| SHIELD THERAPEUTICS INC | 2 | $32 |
| Biogen, Inc. | 1 | $30 |
| MILLICENT US INC | 2 | $30 |
| Bracco Diagnostics Inc. | 1 | $22 |
Products named: Veozah, BOTOX, Tymlos, EVENITY, ACCRUFER, NEXPLANON, VRAYLAR, ZURZUVAE.
Industry payments across KY — which companies pay providers there.
